Prostate adenocarcinoma
Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma
... Prostate adenocarcinoma (CaP) is the second leading cause of male cancer death in the Western world (1). Various risk groups (low, inter- mediate, high, and metastatic) that reflect relative survival are ...
13
A novel combination of multiple primary carcinomas: Urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma report of a case and review of the literature
... 2A) adenocarcinoma of the prostate (the greatest measured focus was ...for Prostate Specific antigen (PSA) (Figure 2C) whereas; no expression of carcinoembryonic antigen (CEA) was detected in tumor ...
6
Coexisting Mantle Cell Lymphoma and Prostate Adenocarcinoma
... and prostate adenocarcinoma (PCa) in an elderly male and review the morphologic features of classic and rare prostatic MCL ...of prostate is done quite routinely, this paper draws attention to the ...
5
Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes
... synchronous prostate adenocarcinoma confined to the prostate and regional pelvic lymph nodes, without metastatic ...as prostate cancer in draining level 4 cervical lymph nodes ...metastatic ...
5
A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma
... cancer showed similar levels of BMD and lower rates of osteoporosis when compared with healthy controls. Assessed individually, three studies showed similar levels of BMD between PCa patients and healthy controls ...
10
Metastatic Prostate Adenocarcinoma Presenting Central Diabetes Insipidus
... Copyright © 2012 Hakkı Yılmaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
5
Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma
... all prostate carcinomas reveal NE ...of prostate cancer and are “freely” dispersed throughout the ...of prostate cancer too ...metastatic prostate can- cer ...in prostate cancer ...
5
Prostate Adenocarcinoma: are EGFR-targeted drugs of therapeutic relevance for castrate-resistant patients?
... Both clinical and experimental data have established the importance of the epidermal growth factor receptor (EGFR) in carcinogenesis and progression of various types of solid tumors including prostate cancer [1]. ...
6
Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
... human prostate-specific antigen (PSA) using an antibiotic resistance marker-free plasmid (the dal dat ⌬ actA 142 strain expressing ...the prostate adenocarcinoma cell line expressing ...
8
Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment
... (father). Prostate-specific antigen (PSA) was initially elevated at ...ever, prostate biopsy was ...repeat prostate biopsy re- vealed Gleason 4 + 5 = 9 prostate adenocarcinoma in- ...
7
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
... with prostate adenocarcinoma, treated with dual ICPIs comprised of ipilimumab and nivolumab, who developed elevated liver enzymes in the context of infliximab therapy prescribed to treat gastrointestinal ...
8
Diagnosis of the Dogs Prostatic Diseases
... by prostate adenome, Granulomatous prostatitis, prostate stones, chronic prostatitis, ...Early prostate cancer detection, diagnosis and appropriate therapy for each patient diagnosed in order to ...
5
Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment
... Human prostate adenocarcinoma cells PC-3 were cultured in F-12 Kaighn’s medium (Invitrogen, Merelbeke, Belgium) supplemented with 7% Foetal Bovine Serum (FBS) (Lonza, Verviers, ...Human prostate ...
17
Metastatic (Advanced) Prostate Cancer Resistant to Castration: The Time before Resistance Development and Therapeutic Measures Undertaken in Cote d’Ivoire
... This is both retro and prospective study over three years (January 01, 2014-De- cember 31, 2016). This study was carried out in the Department of Oncology of the University Teaching Hospital of Treichville in Abidjan and ...
7
Cancer-secreted AGR2 induces programmed cell death in normal cells
... in prostate stromal cells in culture, which is due to the loss of cytoskeletal ...was prostate primary tumors, prostate adenocarcinoma xenografts, as well as prostate cancer ...benign ...
10
In vitro anticancer screening of 24 locally used Nigerian medicinal plants
... The six selected cancer cell lines used in this research were derived from human breast adenocarcinoma MCF- 7 (ATCC No. HTB-22), BT-20 (ATCC No. HTB-19), BT-549 (ATCC No. HTB-122), prostate ...
10
siAh in prostAte cAncer development And progression
... aggressive prostate tumors – namely, neuroendocrine (NE) prostate tumors and prostate adenocarcinoma (PCa) harboring neuroendocrine ...and prostate tumor development and highlight ...
7
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
... Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer which does not respond to hormone ...transplantable adenocarcinoma line (LTL331) and its NEPC subline (LTL331R), we ...
15
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival
... Human prostate adenocarcinoma LNCaP cells were obtained from American Type Culture Collection (ATCC, Manassas, VA). The 7536 – base pair human FASN cDNA previously generated by ligation of four fragments ( ...
14
Cucurbitacin L 2 O β Glucoside demonstrates apoptogenesis in colon adenocarcinoma cells (HT 29): involvement of reactive oxygen and nitrogen species regulation
... The panel of cell lines used in this study were human hepatocellular carcinoma cells HepG2, prostate adenocarcinoma cells PC3, colon adenocarcinoma cells HT-29, non-small-cell lung cance[r] ...
8